Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Carcinomatous meningitis in solid tumours

G C Jayson1, A Howell

  • 1Department of Medical Oncology, Christie Hospital and NHS Trust, Withington, Manchester, UK.

Annals of Oncology : Official Journal of the European Society for Medical Oncology
|October 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A new, ultra-stable lab for nano-metrology of x-ray optics at Diamond Light Source.

The Review of scientific instruments·2025
Same author

Socioeconomic and ethnic disparities in preterm births in an English maternity setting: a population-based study of 1.3 million births.

BMC medicine·2024
Same author

Tamoxifen evolution.

British journal of cancer·2023
Same author

Safety of the use of gold nanoparticles conjugated with proinsulin peptide and administered by hollow microneedles as an immunotherapy in type 1 diabetes.

Immunotherapy advances·2022
Same author

Plasma Tie2 trajectories identify vascular response criteria for VEGF inhibitors across advanced biliary tract, colorectal and ovarian cancers.

ESMO open·2022
Same author

The impact of the COVID-19 pandemic on UK medical education. A nationwide student survey.

Medical teacher·2021
Same journal

The ethical obligation to use positive trial results.

Annals of oncology : official journal of the European Society for Medical Oncology·2026
Same journal

Lorlatinib: The Crown Jewel of ALK Inhibitors.

Annals of oncology : official journal of the European Society for Medical Oncology·2026
Same journal

TROP2-Directed Antibody Drug Conjugates: New First-Line Treatment for All Patients with Advanced Triple-Negative Breast Cancer?

Annals of oncology : official journal of the European Society for Medical Oncology·2026
Same journal

When artificial intelligence learns to abstain: towards clinically responsible diagnostic support in liver pathology.

Annals of oncology : official journal of the European Society for Medical Oncology·2026
Same journal

PRMT5 inhibitors in MTAP loss NSCLC with actionable genomic alterations: a new kid on the block?

Annals of oncology : official journal of the European Society for Medical Oncology·2026
Same journal

Refining decision making in hormone receptor-positive early-stage breast cancer: moving from static to dynamic.

Annals of oncology : official journal of the European Society for Medical Oncology·2026
See all related articles

Carcinomatous meningitis (CM) management lacks clear guidelines due to varied patient groups and response definitions. More research is needed to establish effective treatments and improve patient survival and neurological status.

Area of Science:

  • Neuro-oncology
  • Malignancy Complications
  • Cancer Metastasis

Background:

  • Carcinomatous meningitis (CM) is a rare but severe complication of cancer.
  • Current management strategies for CM are debated, lacking definitive recommendations.
  • Variability in primary tumor types and survival intervals complicates CM research.

Purpose of the Study:

  • To review the challenges in managing carcinomatous meningitis.
  • To highlight the need for standardized research methodologies in CM.
  • To emphasize the importance of patient-centered outcomes in CM treatment evaluation.

Main Methods:

  • Literature review of existing studies on carcinomatous meningitis.
  • Analysis of factors contributing to management controversy.

Related Experiment Videos

  • Assessment of current treatment modalities and their limitations.

    • Main Results:

    • Median survival for solid tumor CM is 2-3 months, with breast cancer patients surviving longer (3 months).
    • Treatment often involves radiotherapy and chemotherapy, but their relative benefits are unknown.
    • Existing studies lack consistent definitions for response and patient stratification (e.g., parenchymal metastases).

    Conclusions:

    • Clear treatment guidelines for carcinomatous meningitis are currently unavailable.
    • There is a critical need for multicenter, prospective, randomized trials.
    • Future research must prioritize patient-relevant endpoints like neurological status and overall survival.